发明名称 |
PHARMACEUTICAL COMBINATION COMPRISING NUCLEOTIDE AND NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (SUCH AS TENOFOVIR AND LAMIVUDINE) IN DIFFERENT PARTS OF THE DOSAGE UNIT |
摘要 |
<p>A pharmaceutical formulation for the treatment of HIV is provided. The formulation is a combination of a nucleoside reverse transcriptase inhibitor and a nucleotide reverse transcriptase inhibitor in which the combination has an increased stability over prior, art combination therapies. The invention also provides a pharmaceutical product containing the formulation.</p> |
申请公布号 |
KR20080091767(A) |
申请公布日期 |
2008.10.14 |
申请号 |
KR20087016727 |
申请日期 |
2008.07.09 |
申请人 |
CIPLA LTD. |
发明人 |
LULLA AMAR;MALHOTRA GEENA |
分类号 |
A61K9/24;A61K31/5513;A61K31/7068;A61P31/18 |
主分类号 |
A61K9/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|